Valuation Indivior Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
40.52 ^USD	+0.04%		-0.04%	+12.95%

06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index	CI
06-28	Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,941	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	10.29%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,995	4,537	4,013
Change	-	55.81%	-17.52%	-21.95%	193.72%	8.51%	-9.17%	-11.56%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	12.8x	11.2x	10.4x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0.1x	0.8x	1.29x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.92x	3.76x	3.6x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.96x	3.46x	2.92x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	7.55x	6.5x	5.59x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	7.95x	6.79x	5.74x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	13.9x	9.36x	7.45x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	7.21%	10.7%	13.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.175	3.61	3.9
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,260	1,312	1,374
EBITDA ¹	202	225	288	338	428	661.2	697.6	718.4
EBIT ¹	187	212	269	312	415	628.2	668.3	698.8
Net income ¹	205	-53	2	-48	210	414.5	472.9	517.4
Net Debt ¹	-860	-534	-77	14	124	54.5	-403.4	-928
Reference price ²	17.25	21.75	15.27	12.43	35.88	40.52	40.52	40.52
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	121,922	-	-
Announcement Date	2/16/22	2/16/23	2/22/24	2/20/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	12.76x	3.96x	7.55x	-	4.94B
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	33.87x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	16.49x	6.29x	15.92x	2.4%	364.84B
Weighted average by Cap.	24.94x	7.94x	18.69x	1.96%